JolantaMalyszko Medical University of Warsaw, PolandPoland

JolantaMalyszko
I am board certified specialist in internal medicine, nephrology, clinical transplantation, hypertension and diabetology. In 1995 I received Ph.D. at Hamamatsu University School of Medicine, Japan. Head of Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University from December 2018. My clinical training was performed in France, Germany, UK, Israel. Member of EDRA-EDTA Executive Council (2015-2018). Member of the Executive Council of KDIGO (2019-2022). Member of Ceartal Eastern Europe -Vice Chair, ISN (2023-2025). My major research interest are: hypertension, cardiovascular complications in CKD, iron metabolism and anemia, onconephrology, AKI. I am author and co-author of over 800 original papers in peer-reviewed journals, (IF~1600, citations >9000 and h-index-50).
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/d134cec909bc5de513af8a27b1661f74.jpg
First Name
Jolanta
Last Name
Malyszko
Institution
Country.
Poland

Friday, February 7, 2025

Time Session
9:45 a.m.
11:15 a.m.
Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course
GeorgiAbraham Chair MGM Healthcare, Chennai, IndiaIndia
KriangTungsanga Chair Department of Medicine, Faculty of Medicine, Chulalongkorn UnviersityThailand
SanjayD'Cruz Chair Government Medical College & Hospital, ChandigarhIndia
  • Renal Complications of Novel Cancer Therapies: Practical Insights
    AnushreeShirali Speaker Yale UniversityUnited States
  • Immune Checkpoint Inhibitors and AKI
    MitchellRosner Speaker Univeristy of Virginia HealthUnited States
  • Electrolyte Abnormalities in the Cancer Patient
    JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland
  • Opening an Onconephrology Clinic - What Should You Be Aware of?
    KenarJhaveri Speaker Northwell HealthUnited States
  • Q&A
Amaltas Hall B101-A

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
Is the Future Now? Precision Medicine, Omics and AI for Kidney Health
JolantaMalyszko Chair Medical University of Warsaw, PolandPoland
ValentineLobo Chair Nephrology Unit, King Edward Memorial Hospital, PuneIndia
  • Deciphering the Molecular Development of Kidney Disease: Transition From AKI to CKD
    SanjayJain Speaker Washington University School of MedicineUnited States
  • KidGen Consortium - Integrating Genomic Medicine Into Care
    AndrewMallett Speaker JCU & THHSAustralia
  • Metadata Ontology, Knowledge Integration, and Kidney Precision Medicine
    MatthiasKretzler Speaker University of MichiganUnited States
  • Kidney Health Professionals and AI - Pioneers or Passive Users?
    GirishNadkarni Speaker Icahn School of Medicine at Mount Sinai and the Mount Sinai Health SystemUnited States
  • Q&A
Amaltas Hall B101-A

Thursday, February 6, 2025

Time Session
9 a.m.
11 a.m.
Annual Review of Nephrology Course: Managing Kidney Failure
KenarJhaveri Chair Northwell HealthUnited States
MitchellRosner Chair Univeristy of Virginia HealthUnited States
  • New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors
    JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland
  • New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals
    KrishnaswamySampathkumar Speaker Meenakshi Mission Hospital India
  • Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue?
    Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
  • Q and A
Neelkamal Hall 305